Bipolar Disorder or Schizophrenia |
1.34 |
7 |
1 |
2.2 |
0.67 |
9.9e-02 |
CD40 ERBB2 FES PEMT RFTN2 STAT6 ZMYM4 |
Depressed Affect (Nagel 2018) |
0.94 |
3 |
1 |
2.2 |
0.00 |
1.0e+00 |
CD40 RERE TEF |
Depression (Nagel 2018) |
1.13 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
RERE |
Intelligence (Savage-Jansen 2018) |
0.90 |
5 |
3 |
6.7 |
0.08 |
9.0e-01 |
MPHOSPH9 PSMG1 SULT1A2 SUOX ZNHIT3 |
Neuroticism (Nagel 2018) |
0.98 |
3 |
3 |
6.7 |
0.00 |
1.0e+00 |
CD40 RERE TEF |
Schizophrenia (2018) |
1.29 |
6 |
1 |
2.2 |
0.97 |
1.1e-03 |
FES RERE RFTN2 STAT6 TOM1L2 ZMYM4 |
Worry (Nagel 2018) |
0.95 |
2 |
0 |
0.0 |
0.00 |
1.0e+00 |
PACSIN1 TEF |
Alzheimer’s Disease (including proxy) |
1.11 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
PPOX |
Crohns Disease (2017) |
3.71 |
25 |
16 |
35.6 |
0.27 |
1.4e-01 |
AC010733.5 CCDC116 ERBB2 GSDMA IL18RAP IL1R1 IRF1 KIAA0391 KIAA1109 KIF3A LRRC32 MED24 NAGLU NDFIP1 ORMDL3 RFTN2 RMI2 RP11-111M22.3 RP11-373D23.3 SMAD3 STMN3 SULT1A2 TNFSF4 TRAFD1 ZBTB38 |
Irritable Bowel Disease (IBD) |
4.05 |
25 |
19 |
42.2 |
0.32 |
7.1e-02 |
AC010733.5 BACH2 CCDC116 ERBB2 GSDMA IL18RAP IL1R1 IRF1 KIAA0391 KIAA1109 LINGO4 LOC115110 LRRC32 MED24 NAGLU NDFIP1 ORMDL3 RGS14 RP11-111M22.3 RP11-373D23.3 SMAD3 SMARCE1 STMN3 SULT1A2 TRAFD1 |
Ulcerative Colitis (UC) |
3.12 |
15 |
8 |
17.8 |
0.19 |
4.4e-01 |
AC010733.5 ERBB2 GSDMA IL1R1 IRF1 KIAA1109 LOC115110 LRRC32 MED24 OIP5 ORMDL3 RGS14 SMAD3 SMARCE1 STMN3 |
Reaction Time |
0.93 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
MIER1 |
Verbal and Numeric Reasoning (VNR) |
0.93 |
3 |
2 |
4.4 |
0.00 |
1.0e+00 |
SULT1A2 SUOX ZNHIT3 |
Breast Cancer |
2.12 |
13 |
7 |
15.6 |
0.70 |
2.6e-03 |
C11orf68 CFL1 DKFZp761E198 EFEMP2 EIF1AD FAM114A1 NAGLU OVOL1 SNX32 TLR1 TLR10 TTC28 ZBTB38 |
Ovarian Cancer |
1.27 |
2 |
0 |
0.0 |
0.00 |
1.0e+00 |
ABO TTC28 |
Prostate Cancer |
2.79 |
3 |
1 |
2.2 |
0.00 |
1.0e+00 |
NCOA4 STMN3 WBP1L |
Age at First Birth |
1.18 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
TRAF3 |
Body Mass Index (BMI) (2010) |
1.21 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
SULT1A2 |
Coronary Artery Disease (CAD) |
1.61 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
ABO |
Crohns Disease (2012) |
2.97 |
15 |
7 |
15.6 |
0.50 |
5.8e-02 |
AC010733.5 CCDC116 ERBB2 GSDMA IL18RAP IRF1 LRRC32 MSTO2P NAGLU NDFIP1 RFTN2 RP11-373D23.3 SMAD3 STMN3 SULT1A2 |
HbA1C |
1.02 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
ADAM1A |
HDL Cholesterol |
1.56 |
5 |
2 |
4.4 |
-0.80 |
5.4e-02 |
CCDC116 ERBB2 GSDMA ORMDL3 PACSIN1 |
LDL Cholesterol |
1.07 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
ABO |
Lupus |
2.12 |
6 |
3 |
6.7 |
0.32 |
4.5e-01 |
CCDC116 DEXI ICAM5 ORMDL3 RP11-876N24.4 SCAMP2 |
Primary Biliary Cirrhosis |
2.75 |
8 |
6 |
13.3 |
0.15 |
6.8e-01 |
DEXI ERBB2 ICAM5 IL7R NFKB1 ORMDL3 RMI2 RP11-876N24.4 |
Rheumatoid Arthritis |
1.97 |
4 |
1 |
2.2 |
-0.01 |
9.9e-01 |
CD40 ERBB2 NRROS TRAF6 |
Schizophrenia (2014) |
1.26 |
6 |
1 |
2.2 |
0.66 |
1.5e-01 |
FES MPHOSPH9 RERE RFTN2 STAT6 TOM1L2 |
Triglycerides |
0.91 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
RP11-373D23.3 |
Type 2 Diabetes (T2D) (2012) |
1.39 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
JAZF1 |
Ulcerative Colitis |
2.82 |
9 |
6 |
13.3 |
0.16 |
6.8e-01 |
AC010733.5 ERBB2 GSDMA IL1R1 KIAA1109 LOC115110 ORMDL3 STMN3 TMEM170A |
Blood Eosinophil Count |
11.50 |
89 |
77 |
171.1 |
0.80 |
8.4e-26 |
ABO ADAM1A AHI1 BACH2 BANF1 C11orf68 CAMK4 CAPSL CASC3 CCDC116 CD247 CFL1 CHP CLCN6 CLIC4 DEXI DKFZp761E198 EFEMP2 EIF1AD FAM114A1 FOXO1 GLDC GPR182 GSDMA IL18RAP IL1R1 IL1R2 IL1RL1 IL2RA IL7R IRF1 JMJD5 KIAA1109 KIF3A LCLAT1 LOC115110 LRRC32 MED24 MPHOSPH9 NADKD1 NDFIP1 NDUFAF1 NEK6 NRROS NUSAP1 OIP5 ORMDL3 OVOL1 PCNXL3 PIBF1 POLI PPOX PRKCQ RANBP6 RASSF5 RERE RGS14 RIN3 RMI2 RP11-305L7.1 RP11-396B14.2 RP11-876N24.4 RP11-876N24.5 RTF1 SIK2 SLC25A46 SLC9A2 SMAD3 SMAD4 SMARCE1 SNX32 SPATA5 SPEF2 SPPL3 STAT6 SUGT1L1 SUOX TEF TLR10 TLR6 TOM1L2 TRAFD1 TSLP UBAC2 UGT3A2 WDR36 ZBTB7B ZNF652 ZNHIT3 |
Blood Platelet Count |
1.96 |
44 |
35 |
77.8 |
0.12 |
4.3e-01 |
ADAM1A C11orf68 C1orf43 CASC3 CFL1 CLIC4 EFEMP2 EIF1AD ERBB2 FAM69A FOXO1 IL6R IRF1 KIAA1109 KIF3A MLXIP MPHOSPH9 NDFIP1 ORMDL3 OVOL1 PACSIN1 PCNXL3 PSMG1 PTRF RFTN2 RMI2 SGSM2 SIK2 SLC15A2 SNX32 SPPL3 STMN3 SUGT1L1 SULT1A2 TEF TLR10 TMEM170A TRAF1 TRAF3 TRAFD1 TTC28 WBP1L ZBTB7B ZKSCAN5 |
Blood Red Count |
1.45 |
38 |
26 |
57.8 |
-0.14 |
3.9e-01 |
ABO ADAM1A AHI1 BACH2 C11orf68 C17orf46 CD40 CFL1 CHP CLCN6 CLIC4 EIF1AD ERBB2 FAM69A FOXO1 LINGO4 MLXIP NDFIP1 NFKB1 ORMDL3 POLI RFTN2 RGS14 RTF1 SCAMP2 STMN3 SUGT1L1 SULT1A2 SUOX TLR1 TLR10 TLR6 TRAF3 TRAFD1 TTC28 ZBTB38 ZBTB7B ZNF217 |
Blood White Count |
8.27 |
59 |
35 |
77.8 |
0.28 |
2.1e-02 |
ABO AC010733.5 ADAM1A AHI1 ARHGAP15 BACH2 BANF1 C11orf68 C17orf46 CALCRL CAPSL CASC3 CCDC116 CFL1 CHP DEXI EFEMP2 EIF1AD ERBB2 FAM69A FES GSDMA ICAM5 IL1R2 IQGAP1 IRF1 JAZF1 KIF3A MED24 MIER1 NAGLU NDFIP1 NUSAP1 ORMDL3 PACSIN1 PEMT PIGX POLI PPOX RERE RGS14 RIN3 RP11-305L7.1 RP11-373D23.3 RP11-396B14.2 RP11-876N24.4 RP11-876N24.5 RTF1 SCML4 SGSM2 SNX32 TLR10 TOM1L2 TRAF1 TRAF3 TRAFD1 WBP1L ZMYM4 ZNF217 |
Heel T-Score |
1.17 |
20 |
15 |
33.3 |
0.09 |
6.9e-01 |
ABO CALCRL CCDC116 EIF1AD IQGAP1 JAZF1 LCLAT1 MPHOSPH9 NEK6 OVOL1 PCNXL3 RERE RIN3 SCAMP2 SGSM2 SLC15A2 TEF TTC28 ZBTB38 ZNF774 |
BMI |
1.52 |
28 |
15 |
33.3 |
-0.55 |
2.3e-03 |
ARHGAP15 CFL1 DKFZp761E198 EFEMP2 FAM69A GSDMA ICAM5 LOC115110 MLXIP MSTO2P NAGLU NEK6 NUSAP1 OIP5 PACSIN1 PSMG1 SGSM2 SNX32 STMN3 SULT1A2 SUOX TLR1 TLR10 TMEM170A TRAF3 TRAFD1 ZBTB7B ZNHIT3 |
Height |
1.77 |
53 |
39 |
86.7 |
-0.12 |
3.8e-01 |
ABO ARHGAP15 BANF1 C11orf68 CALCRL CCDC116 CFL1 CHP DKFZp761E198 EFEMP2 EIF1AD FAM114A1 FAM69A FCHSD1 IL18RAP IL1R1 IL7R IQGAP1 IRF1 JAZF1 KIAA1109 KIF3A LMBRD2 MGAT5 MIER1 MLXIP MPHOSPH9 NDUFAF1 NFKB1 NUSAP1 OIP5 PACSIN1 PCNXL3 POGZ PTRF RERE RGS14 RP11-373D23.3 RTF1 SNX32 SPEF2 SPPL3 STAT6 SUGT1L1 TLR1 TLR6 TMEM170A UGT3A2 WBP1L ZBTB38 ZBTB7B ZNF652 ZNF774 |
Waist Hip Ratio (WHR) |
1.59 |
23 |
11 |
24.4 |
-0.27 |
1.9e-01 |
ADAM1A BANF1 CALCRL CLEC16A DEXI EIF1AD ENDOG GSAP JAZF1 MED24 MLXIP MPHOSPH9 NAGLU PACSIN1 PTRF RP11-876N24.5 SIK2 TOM1L2 WBP1L ZBTB38 ZBTB7B ZMYM4 ZNHIT3 |
Systolic Blood Pressure |
1.90 |
21 |
16 |
35.6 |
-0.01 |
9.5e-01 |
ADAM1A C17orf46 CHP CLCN6 CLIC4 FES LOC729082 MLXIP PTRF RERE RP11-111M22.3 RP11-373D23.3 RTF1 SCAMP2 SIK2 SLC15A2 SNX32 TMEM170A TRAFD1 ZMYM4 ZNF652 |
Smoking Status |
1.30 |
6 |
2 |
4.4 |
0.22 |
6.8e-01 |
ADAM1A FES RERE SUOX WBP1L ZNF652 |
Cardiovascular Disease |
1.85 |
16 |
9 |
20.0 |
-0.02 |
9.3e-01 |
ADAM1A CHP CLCN6 FES IRF1 LOC729082 NDUFAF1 NUSAP1 RTF1 SCAMP2 SIK2 SMARCE1 SUOX TMEM170A TRAFD1 ZNF652 |
Hypothyroidism (self reported) |
2.96 |
22 |
9 |
20.0 |
-0.03 |
8.9e-01 |
AC010733.5 ADAM1A AHI1 BACH2 CD247 CFL1 ENDOG IL7R KIAA1109 MLXIP NEK6 PTRF RERE SLC15A2 SPPL3 SUOX TEF TLR1 TLR10 TRAF1 TRAFD1 UBAC2 |
Respiratory disease |
13.94 |
73 |
51 |
113.3 |
0.91 |
7.9e-40 |
AC008781.7 AHI1 BACH2 C17orf46 CAMK4 CASC3 CD247 CHP DEXI EFEMP2 ERBB2 FAM114A1 FOXO1 GLDC GPR182 GSDMA IL18RAP IL1R1 IL1RL1 IL2RA IL6R IL7R IRF1 JAZF1 JMJD5 KIAA1109 KIAA1432 KIF3A LINGO4 LRRC32 MED24 MPHOSPH9 NDFIP1 NDUFAF1 NEK6 NRROS NUSAP1 ORMDL3 POLI PPOX PRKCQ PSMG1 RANBP6 RERE RGS14 RIN3 RP11-396B14.2 RP11-876N24.4 RP11-876N24.5 RTF1 S100A11 SCML4 SIK2 SLC15A2 SLC25A46 SLC9A2 SMAD3 SMARCE1 SMCP SPATA5 STAT6 STMN3 SUOX TEF TLR1 TLR10 TNFSF4 TRAF1 TSLP UBAC2 WDR36 ZNF217 ZNF652 |
Type 2 Diabetes (T2D) (2018) |
1.19 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
JAZF1 |
Lung FEV1/FVC ratio |
2.02 |
29 |
14 |
31.1 |
-0.56 |
9.7e-04 |
ABO AC010733.5 AQP5 BACH2 CALCRL FAM69A FOXO1 GLDC IL1RL1 IL7R IRF1 MED24 ORMDL3 PRKCQ RERE RGS14 RP11-396B14.2 RP11-5P18.10 SGSM2 SLC9A2 SMAD3 STAT6 SUGT1L1 SUOX TMEM170A TOM1L2 ZBTB38 ZBTB7B ZNF652 |
Lung FVC |
1.13 |
14 |
7 |
15.6 |
-0.36 |
1.7e-01 |
AHI1 CHP CLCN6 ERBB2 LINGO4 LOC729082 MPHOSPH9 ORMDL3 RIN3 RTF1 SPPL3 STMN3 SUOX ZBTB38 |
Neuroticism |
0.80 |
3 |
2 |
4.4 |
0.00 |
1.0e+00 |
CD40 RERE TEF |
Chronotype (morning person) |
1.08 |
3 |
0 |
0.0 |
0.00 |
1.0e+00 |
KIAA1109 RFTN2 TTC28 |
Hair Pigment |
0.25 |
9 |
6 |
13.3 |
0.49 |
1.3e-01 |
FES JAZF1 KIAA1432 MPHOSPH9 RP11-373D23.3 SUOX TRAF3 ZBTB38 ZBTB7B |
Tanning |
0.25 |
4 |
2 |
4.4 |
0.65 |
2.3e-01 |
JAZF1 MSTO2P RP11-373D23.3 ZBTB7B |
Hand grip strength (left) |
0.96 |
3 |
2 |
4.4 |
0.00 |
1.0e+00 |
IRF1 WBP1L ZBTB38 |
Number of treatments/medications taken |
1.84 |
4 |
0 |
0.0 |
0.36 |
6.4e-01 |
ADAM1A SLC9A2 TRAFD1 ZNF652 |
Frequency of depressed mood in last 2 weeks |
0.99 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
RERE |
Relative age of first facial hair |
1.04 |
3 |
1 |
2.2 |
0.00 |
1.0e+00 |
PSMG1 SPPL3 ZBTB38 |
Ever used hormone-replacement therapy (HRT) |
1.08 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
NEK6 |
Systolic blood pressure, automated reading |
1.76 |
11 |
6 |
13.3 |
0.35 |
2.9e-01 |
C17orf46 CHP CLCN6 FES LOC729082 RERE RTF1 SGSM2 SLC15A2 STMN3 TMEM170A |
Angina |
1.19 |
2 |
0 |
0.0 |
0.00 |
1.0e+00 |
FES ZNF652 |
Vitamin and mineral supplements |
1.22 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
STAT6 |
Medication: Metformin |
1.36 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
JAZF1 |
Impedance of leg (right) |
1.72 |
22 |
12 |
26.7 |
0.64 |
9.4e-04 |
ACY3 AQP5 C11orf68 CFL1 EFEMP2 EIF1AD FCHSD1 JAZF1 MLXIP MSTO2P NAGLU PACSIN1 PEMT RFTN2 RIN3 SGSM2 SNX32 SULT1A2 SUOX TMEM170A ZBTB7B ZNF652 |
Leg fat-free mass (left) |
1.70 |
24 |
11 |
24.4 |
-0.45 |
2.8e-02 |
ARHGAP15 DKFZp761E198 EFEMP2 IRF1 JAZF1 MLXIP MPHOSPH9 MSTO2P NAGLU PACSIN1 PEMT RIN3 RP11-373D23.3 SGSM2 SNX32 SPPL3 SUGT1L1 SULT1A2 SUOX TRAF3 TRAFD1 ZBTB38 ZBTB7B ZNHIT3 |
Trunk fat percentage |
1.31 |
14 |
9 |
20.0 |
-0.35 |
2.1e-01 |
ABO ARHGAP15 MLXIP NUSAP1 OIP5 PACSIN1 RERE RFTN2 SGSM2 SULT1A2 TEF TRAF3 ZBTB38 ZNHIT3 |
Hand grip strength (right) |
0.95 |
6 |
2 |
4.4 |
0.07 |
9.0e-01 |
ABO IL1R1 IRF1 SULT1A2 WBP1L ZBTB38 |
Current tobacco smoking |
1.18 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
STMN3 |
Maternal smoking around birth |
0.94 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
ZNHIT3 |
Fed-up feelings |
0.81 |
2 |
0 |
0.0 |
0.00 |
1.0e+00 |
CD40 TEF |
Relative age voice broke |
1.10 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
SPPL3 |
Taking other prescription medications |
2.77 |
6 |
2 |
4.4 |
0.77 |
4.3e-02 |
ADAM1A DEXI GSDMA IL1RL1 ORMDL3 ZNF652 |
Age when periods started (menarche) |
1.16 |
2 |
1 |
2.2 |
0.00 |
1.0e+00 |
PSMG1 SUOX |
Heel bone mineral density (BMD) T-score, automated (left) |
1.02 |
4 |
3 |
6.7 |
0.44 |
5.6e-01 |
IQGAP1 PCNXL3 RERE ZNF774 |
High blood pressure |
1.89 |
15 |
6 |
13.3 |
-0.10 |
7.3e-01 |
ABO ADAM1A CHP CLCN6 FES LOC729082 NDUFAF1 POLI RERE RTF1 SGSM2 SIK2 SUOX TRAFD1 ZNF652 |
Hayfever, allergic rhinitis or eczema |
22.40 |
148 |
97 |
215.6 |
1.00 |
2.5e-211 |
AC008781.7 AC010733.5 ACY3 ADAM1A AHI1 AQP5 ARHGAP15 BACH2 BANF1 C11orf21 C11orf68 C17orf46 C1orf43 CAMK4 CAPSL CASC3 CCDC116 CD247 CFL1 CHP CLCN6 CLEC16A CLIC4 DEXI DKFZp761E198 EFEMP2 EIF1AD ENDOG ERBB2 ETV7 FAM114A1 FAM69A FCHSD1 FOXO1 GLDC GPR182 GSAP GSDMA ICAM5 IL18RAP IL1R1 IL1RL1 IL2RA IL6R IL7R IQGAP1 IRF1 JAZF1 JMJD5 KIAA0391 KIAA1109 KIAA1432 KIF3A LCLAT1 LINGO4 LMBRD2 LOC115110 LOC729082 LRRC32 MED24 MGAT5 MIER1 MLXIP MPHOSPH9 MSTO2P NAGLU NCOA4 NDFIP1 NDUFAF1 NEK6 NFKB1 NRROS NUSAP1 ORMDL3 OVOL1 PACSIN1 PCNXL3 PEMT PIBF1 PIGX POLI PPOX PRKCQ PRR5L PSMG1 PTRF RANBP6 RASSF5 RERE RFTN2 RGS14 RIN3 RMI2 RP11-111M22.3 RP11-305L7.1 RP11-373D23.3 RP11-396B14.2 RP11-5P18.10 RP11-876N24.4 RP11-876N24.5 RTF1 S100A11 SCAMP2 SCML4 SGSM2 SIK2 SLC15A2 SLC25A46 SLC9A2 SMAD3 SMAD4 SMARCE1 SNX32 SPATA5 SPEF2 SPPL3 STAT6 STMN3 SUGT1L1 SULT1A2 SUOX TDRKH TEF TLR1 TLR10 TLR6 TMEM170A TMEM232 TNFSF4 TOM1L2 TRAF1 TRAF3 TRAF6 TRAFD1 TSLP TTC28 UBAC2 UGT3A2 WBP1L WDR36 ZBTB38 ZBTB7B ZKSCAN5 ZMYM4 ZNF217 ZNF652 ZNF774 ZNHIT3 |
Multivitamins +/- minerals |
1.20 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
STAT6 |
Medication: Atenolol |
1.71 |
2 |
2 |
4.4 |
0.00 |
1.0e+00 |
FES TRAFD1 |
Medication: Levothyroxine sodium |
2.45 |
8 |
5 |
11.1 |
-0.10 |
8.2e-01 |
ADAM1A AHI1 BACH2 IL7R PTRF SLC15A2 SUOX TRAFD1 |
Sitting height |
1.46 |
19 |
13 |
28.9 |
-0.24 |
3.3e-01 |
CALCRL CCDC116 CHP DEXI FAM69A IRF1 JAZF1 MLXIP MPHOSPH9 NDUFAF1 NUSAP1 PACSIN1 RGS14 RTF1 STAT6 WBP1L ZBTB38 ZBTB7B ZNF652 |
High blood pressure (mother) |
1.23 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
FES |
Body mass index (BMI) |
1.49 |
18 |
12 |
26.7 |
-0.74 |
4.0e-04 |
ARHGAP15 CFL1 EFEMP2 LOC115110 MLXIP MSTO2P NAGLU OIP5 PACSIN1 PSMG1 SGSM2 SNX32 SULT1A2 SUOX TMEM170A TRAF3 ZBTB7B ZNHIT3 |
Impedance of leg (left) |
1.68 |
21 |
13 |
28.9 |
0.68 |
5.4e-04 |
C11orf68 CFL1 EFEMP2 EIF1AD FCHSD1 JAZF1 LMBRD2 MLXIP MSTO2P NAGLU PACSIN1 PEMT RFTN2 RIN3 SGSM2 SNX32 SULT1A2 SUOX TMEM170A ZBTB7B ZNF652 |
Leg predicted mass (left) |
1.71 |
25 |
11 |
24.4 |
-0.47 |
1.8e-02 |
ARHGAP15 DKFZp761E198 EFEMP2 FOXO1 IRF1 JAZF1 MLXIP MPHOSPH9 MSTO2P NAGLU PACSIN1 PEMT RIN3 RP11-373D23.3 SGSM2 SNX32 SPPL3 SUGT1L1 SULT1A2 SUOX TRAF3 TRAFD1 ZBTB38 ZBTB7B ZNHIT3 |
Trunk fat mass |
1.39 |
10 |
7 |
15.6 |
-0.46 |
1.8e-01 |
ARHGAP15 MLXIP NAGLU PACSIN1 RERE SGSM2 SULT1A2 TRAF3 ZBTB38 ZNHIT3 |
Waist circumference |
1.46 |
11 |
8 |
17.8 |
-0.65 |
3.1e-02 |
CALCRL MLXIP NAGLU PACSIN1 SGSM2 SNX32 SULT1A2 SUOX TRAF3 ZBTB38 ZNHIT3 |
Past tobacco smoking |
1.18 |
2 |
1 |
2.2 |
0.00 |
1.0e+00 |
ADAM1A WBP1L |
Hair/balding pattern: Pattern 2 |
1.10 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
CLIC4 |
Had menopause |
1.25 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
CHP |
Forced vital capacity (FVC) |
1.06 |
7 |
3 |
6.7 |
-0.54 |
1.3e-01 |
AHI1 LINGO4 PACSIN1 PEMT STMN3 WBP1L ZBTB38 |
Heel bone mineral density (BMD) T-score, automated (right) |
1.05 |
6 |
3 |
6.7 |
0.23 |
6.6e-01 |
IQGAP1 JAZF1 PCNXL3 RERE ZBTB38 ZNF774 |
Qualifications: None of the above |
1.09 |
3 |
3 |
6.7 |
0.00 |
1.0e+00 |
MPHOSPH9 SULT1A2 SUOX |
Heart attack |
1.15 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
ZNF652 |
Allergy |
22.25 |
132 |
98 |
217.8 |
-0.99 |
4.8e-136 |
ABO AC008781.7 AC010733.5 AHI1 AQP5 BACH2 BANF1 C11orf21 C11orf68 C17orf46 C1orf43 CAMK4 CAPSL CASC3 CCDC116 CD247 CFL1 CHP CLCN6 CLEC16A CLIC4 CRTAP DEXI DKFZp761E198 EFEMP2 EIF1AD ENDOG ERBB2 ETV7 FAM114A1 FAM69A FCHSD1 FOXO1 GLDC GPR182 GSAP GSDMA IL18RAP IL1R1 IL1R2 IL1RL1 IL2RA IL6R IL7R IQGAP1 IRF1 JAZF1 JMJD5 KIAA0391 KIAA1109 KIAA1432 KIF3A LCLAT1 LINGO4 LMBRD2 LOC115110 LRRC32 MED24 MGAT5 MIER1 MLXIP MPHOSPH9 NADKD1 NAGLU NDFIP1 NDUFAF1 NEK6 NFKB1 NRROS NUSAP1 ORMDL3 OVOL1 PCNXL3 PEMT PIGX POGZ POLI PPOX PRKCQ PRR5L PSMG1 PTRF PVT1 RANBP6 RASSF5 RERE RFTN2 RGS14 RIN3 RMI2 RP11-111M22.3 RP11-373D23.3 RP11-396B14.2 RP11-876N24.4 RP11-876N24.5 RTF1 S100A11 SCML4 SIK2 SLC15A2 SLC25A46 SLC9A2 SMAD3 SMAD4 SMARCE1 SMCP SPATA5 SPEF2 SPPL3 STAT6 STMN3 SUGT1L1 SUOX TEF TLR1 TLR10 TLR6 TMEM232 TNFSF4 TRAF1 TRAF3 TRAFD1 TSLP TTC28 UBAC2 UGT3A2 WBP1L WDR36 ZBTB38 ZKSCAN5 ZNF217 ZNF652 |
Diabetes (self-reported) |
1.18 |
2 |
0 |
0.0 |
0.00 |
1.0e+00 |
JAZF1 NAGLU |
Hayfever/allergic rhinitis (self-reported) |
10.45 |
36 |
17 |
37.8 |
0.98 |
9.7e-35 |
BACH2 CAMK4 CD247 CFL1 DEXI FAM114A1 GLDC GPR182 IL18RAP IL1RL1 IL7R IQGAP1 KIAA1109 LMBRD2 LRRC32 ORMDL3 PEMT PPOX RANBP6 RFTN2 RP11-396B14.2 RP11-876N24.4 SLC25A46 SLC9A2 SMAD3 SMARCE1 SPATA5 STAT6 SUOX TLR1 TLR10 TNFSF4 TSLP UGT3A2 WDR36 ZKSCAN5 |
Medication: Ramipril |
1.28 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
ADAM1A |
Medication: Simvastatin |
1.24 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
ABO |
Fluid intelligence score |
1.00 |
4 |
1 |
2.2 |
0.29 |
7.1e-01 |
MPHOSPH9 SULT1A2 SUOX ZNHIT3 |
Illnesses of siblings |
1.57 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
FES |
Neuroticism score |
0.75 |
3 |
0 |
0.0 |
0.00 |
1.0e+00 |
CD40 RERE TEF |
Weight |
1.63 |
17 |
11 |
24.4 |
-0.47 |
5.5e-02 |
ARHGAP15 DKFZp761E198 EFEMP2 FOXO1 MLXIP NAGLU PACSIN1 RP11-373D23.3 SGSM2 SNX32 SULT1A2 SUOX TRAF3 TRAFD1 ZBTB38 ZBTB7B ZNHIT3 |
Impedance of arm (right) |
1.96 |
25 |
18 |
40.0 |
0.68 |
6.2e-05 |
ABO C11orf68 C1orf43 CFL1 DKFZp761E198 EFEMP2 FCHSD1 GSDMA ICAM5 JAZF1 LCLAT1 LRRC32 MED24 NEK6 ORMDL3 OVOL1 PACSIN1 RFTN2 RIN3 SNX32 SUOX TEF TRAFD1 ZBTB7B ZNF652 |
Arm fat percentage (right) |
1.34 |
15 |
9 |
20.0 |
-0.44 |
1.0e-01 |
ABO ARHGAP15 MLXIP MSTO2P NAGLU NUSAP1 OIP5 PACSIN1 RERE SGSM2 SULT1A2 SUOX TMEM170A TRAF3 ZNHIT3 |
Trunk fat-free mass |
1.78 |
24 |
13 |
28.9 |
-0.43 |
3.7e-02 |
ABO ARHGAP15 CHP DKFZp761E198 EFEMP2 IRF1 MLXIP MPHOSPH9 NDUFAF1 PACSIN1 PEMT RFTN2 RIN3 RP11-373D23.3 RTF1 SPPL3 STAT6 SULT1A2 SUOX TRAF3 TRAFD1 WBP1L ZBTB38 ZBTB7B |
Hip circumference |
1.69 |
18 |
6 |
13.3 |
-0.36 |
1.4e-01 |
CLCN6 DKFZp761E198 EFEMP2 FOXO1 GSDMA MLXIP PACSIN1 PSMG1 RP11-373D23.3 STMN3 SULT1A2 SUOX TLR10 TRAF3 TRAFD1 ZBTB38 ZBTB7B ZNHIT3 |
Father's age at death |
1.39 |
2 |
0 |
0.0 |
0.00 |
1.0e+00 |
ABO FES |
Hair/balding pattern: Pattern 3 |
0.86 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
CLIC4 |
Number of live births |
1.18 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
NFKB1 |
Forced expiratory volume in 1-second (FEV1) |
1.06 |
5 |
1 |
2.2 |
-0.31 |
6.1e-01 |
ABO AHI1 PACSIN1 SUOX ZBTB38 |
Pulse rate |
0.99 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
ZBTB38 |
Qualifications: A levels/AS levels or equivalent |
0.87 |
2 |
1 |
2.2 |
0.00 |
1.0e+00 |
MPHOSPH9 SUOX |
Mouth/teeth dental problems: Dentures |
1.23 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
PPOX |
Asthma |
14.12 |
63 |
46 |
102.2 |
0.92 |
3.1e-37 |
AHI1 BACH2 CAMK4 CASC3 CD247 DEXI DKFZp761E198 EFEMP2 ERBB2 FAM114A1 GLDC GPR182 GSDMA IL18RAP IL1R1 IL1RL1 IL7R IRF1 JAZF1 JMJD5 KIAA1109 KIAA1432 KIF3A LINGO4 LRRC32 MED24 NAGLU NDFIP1 NDUFAF1 NRROS ORMDL3 POLI PPOX PRKCQ RANBP6 RERE RGS14 RIN3 RP11-396B14.2 RP11-876N24.4 RP11-876N24.5 RTF1 S100A11 SCML4 SIK2 SLC25A46 SLC9A2 SMAD3 SMARCE1 SMCP SPPL3 STAT6 STMN3 SUOX TEF TLR1 TLR10 TMEM232 TNFSF4 TSLP UBAC2 WDR36 ZNF652 |
Medication: Ibuprofen (e.g. Nurofen) |
1.11 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
STAT6 |
Medication: Cholesterol lowering |
1.23 |
2 |
1 |
2.2 |
0.00 |
1.0e+00 |
ABO FES |
Depression (self-reported) |
1.01 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
RERE |
Illnesses of mother |
1.20 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
FES |
Forced expiratory volume in 1-second (FEV1), Best measure |
1.05 |
5 |
1 |
2.2 |
-0.51 |
3.8e-01 |
ABO LINGO4 PACSIN1 SUOX ZBTB38 |
Pulse wave Arterial Stiffness index |
1.51 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
ADAM1A |
Impedance of arm (left) |
1.91 |
23 |
15 |
33.3 |
0.69 |
1.7e-04 |
ABO C11orf68 C1orf43 CFL1 EFEMP2 FCHSD1 GSDMA JAZF1 LRRC32 MED24 NEK6 ORMDL3 OVOL1 PACSIN1 RFTN2 RIN3 RP11-373D23.3 SNX32 SUOX TEF TRAFD1 ZBTB7B ZNF652 |
Arm fat mass (right) |
1.43 |
15 |
11 |
24.4 |
-0.65 |
8.2e-03 |
ARHGAP15 EFEMP2 FOXO1 MLXIP MSTO2P NAGLU PACSIN1 SGSM2 SNX32 SULT1A2 SUOX TRAF3 ZBTB38 ZBTB7B ZNHIT3 |
Trunk predicted mass |
1.79 |
24 |
13 |
28.9 |
-0.38 |
6.5e-02 |
ABO ARHGAP15 CHP DKFZp761E198 EFEMP2 IRF1 MLXIP MPHOSPH9 NDUFAF1 NEK6 PACSIN1 PEMT RFTN2 RIN3 RP11-373D23.3 SPPL3 STAT6 SULT1A2 SUOX TRAF3 TRAFD1 WBP1L ZBTB38 ZBTB7B |
Standing height |
1.64 |
28 |
22 |
48.9 |
-0.25 |
1.9e-01 |
CFL1 CHP EIF1AD FAM69A FCHSD1 IL1R1 IQGAP1 IRF1 MGAT5 MIER1 MLXIP MPHOSPH9 NDUFAF1 NUSAP1 OIP5 PACSIN1 RGS14 RP11-373D23.3 RTF1 SPPL3 STAT6 SUGT1L1 TMEM170A WBP1L ZBTB38 ZBTB7B ZNF652 ZNF774 |
Breastfed as a baby |
1.15 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
MPHOSPH9 |
Tense / 'highly strung' |
1.05 |
2 |
1 |
2.2 |
0.00 |
1.0e+00 |
RERE TEF |
Hair/balding pattern: Pattern 4 |
1.48 |
7 |
4 |
8.9 |
-0.12 |
8.1e-01 |
C17orf46 CLIC4 IQGAP1 RP11-5P18.10 S100A11 ZBTB38 ZNF774 |
Birth weight of first child |
1.70 |
7 |
4 |
8.9 |
0.52 |
2.3e-01 |
CLCN6 FES SUOX TMEM170A TRAFD1 ZBTB38 ZKSCAN5 |
Peak expiratory flow (PEF) |
0.97 |
2 |
1 |
2.2 |
0.00 |
1.0e+00 |
ABO TMEM170A |
Qualifications: O levels/GCSEs or equivalent |
0.96 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
MPHOSPH9 |
Blood clot in the leg (DVT) |
2.08 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
ABO |
Medication: Paracetamol |
1.23 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
STAT6 |
Headache pain in last month |
1.50 |
3 |
1 |
2.2 |
0.00 |
1.0e+00 |
STAT6 SUOX TMEM170A |
Medication for cholesterol, blood pressure or diabetes |
1.58 |
4 |
3 |
6.7 |
0.59 |
4.1e-01 |
CLCN6 FES SIK2 ZNF652 |
Gout (self-reported) |
1.61 |
3 |
1 |
2.2 |
0.00 |
1.0e+00 |
MLXIP OVOL1 PCNXL3 |
Hypothyroidism/myxoedema (self-reported) |
2.69 |
12 |
6 |
13.3 |
-0.12 |
7.0e-01 |
ADAM1A AHI1 BACH2 CD247 KIAA1109 MLXIP PTRF RERE SLC15A2 SUOX TEF TRAFD1 |
Medication: Amlodipine |
1.22 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
FES |
Medication: Ventolin 100micrograms inhaler |
6.49 |
17 |
8 |
17.8 |
0.93 |
9.2e-10 |
CD247 ERBB2 FOXO1 GLDC GSDMA IL18RAP IL1RL1 KIAA1109 LRRC32 NDFIP1 ORMDL3 SLC9A2 SMAD3 STAT6 SUOX TLR1 ZNF652 |
Birth weight |
1.68 |
8 |
2 |
4.4 |
-0.18 |
6.7e-01 |
ADAM1A FES MIER1 NFKB1 SIK2 TRAF1 TRAFD1 ZBTB7B |
High blood pressure (siblings) |
1.59 |
2 |
2 |
4.4 |
0.00 |
1.0e+00 |
CLCN6 FES |
Forced vital capacity (FVC), Best measure |
0.98 |
5 |
1 |
2.2 |
-0.49 |
2.6e-01 |
AHI1 LINGO4 PACSIN1 STMN3 ZBTB38 |
Body fat percentage |
1.33 |
15 |
7 |
15.6 |
-0.20 |
4.7e-01 |
ABO ARHGAP15 MLXIP NAGLU NUSAP1 OIP5 PACSIN1 RERE SGSM2 STMN3 SULT1A2 TEF TRAF3 ZBTB38 ZNHIT3 |
Leg fat percentage (right) |
1.36 |
13 |
8 |
17.8 |
0.23 |
4.5e-01 |
ARHGAP15 CHP MLXIP NRROS NUSAP1 OIP5 PACSIN1 RERE SNX32 STMN3 SULT1A2 TRAF3 ZNHIT3 |
Arm fat-free mass (right) |
1.85 |
19 |
16 |
35.6 |
-0.41 |
8.0e-02 |
ABO ARHGAP15 DKFZp761E198 EFEMP2 MLXIP MPHOSPH9 NEK6 PACSIN1 RFTN2 RIN3 RP11-373D23.3 SNX32 SULT1A2 SUOX TRAF3 TRAFD1 WBP1L ZBTB38 ZBTB7B |
Comparative body size at age 10 |
1.66 |
12 |
6 |
13.3 |
-0.80 |
1.7e-03 |
C11orf68 CFL1 EFEMP2 EIF1AD MIER1 OVOL1 PCNXL3 SGSM2 SNX32 SULT1A2 ZNF652 ZNHIT3 |
Worry too long after embarrassment |
0.94 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
AHI1 |
Wheeze or whistling in the chest in last year |
5.56 |
26 |
15 |
33.3 |
0.95 |
1.5e-20 |
BACH2 CASC3 CD247 DEXI ERBB2 GLDC GPR182 GSDMA IL1RL1 KIAA1109 LRRC32 MED24 NRROS ORMDL3 RERE RIN3 RP11-396B14.2 RP11-876N24.4 RP11-876N24.5 SIK2 SLC25A46 SLC9A2 SMAD3 STMN3 TSLP WDR36 |
Age at first live birth |
1.06 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
SUOX |
Pulse wave peak to peak time |
1.51 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
ADAM1A |
Shortness of breath walking on level ground |
1.07 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
LRRC32 |
Qualifications: College or University degree |
1.10 |
4 |
3 |
6.7 |
0.64 |
3.6e-01 |
CD40 MPHOSPH9 SULT1A2 SUOX |
Medication for pain relief, constipation, heartburn |
1.23 |
2 |
1 |
2.2 |
0.00 |
1.0e+00 |
MPHOSPH9 STAT6 |
Neck or shoulder pain in last month |
1.06 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
SUOX |
Medication: Blood pressure |
1.69 |
5 |
4 |
8.9 |
-0.56 |
3.2e-01 |
ADAM1A CLCN6 FES SIK2 ZNF652 |
Angina (self-reported) |
1.13 |
2 |
0 |
0.0 |
0.00 |
1.0e+00 |
FES ZNF652 |
Migraine (self-reported) |
1.30 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
STAT6 |
Medication: Ibuprofen |
1.06 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
STAT6 |
Medication: Allopurinol |
1.37 |
4 |
1 |
2.2 |
0.46 |
5.4e-01 |
MLXIP OVOL1 PCNXL3 ZBTB7B |
Medication: Seretide 50 evohaler |
2.99 |
3 |
1 |
2.2 |
0.79 |
2.1e-01 |
IL1RL1 SMAD3 ZNF652 |
Mean time to correctly identify matches |
0.83 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
MIER1 |
Whole body fat mass |
1.40 |
14 |
6 |
13.3 |
-0.28 |
3.4e-01 |
ARHGAP15 EFEMP2 MLXIP NAGLU PACSIN1 RERE SGSM2 SNX32 STMN3 SULT1A2 SUOX TRAF3 ZBTB38 ZNHIT3 |
Leg fat mass (right) |
1.49 |
14 |
9 |
20.0 |
-0.25 |
3.8e-01 |
ARHGAP15 EFEMP2 MLXIP NAGLU OIP5 PACSIN1 RERE SNX32 STMN3 SULT1A2 SUOX TRAF3 ZBTB38 ZNHIT3 |
Arm predicted mass (right) |
1.87 |
20 |
16 |
35.6 |
-0.42 |
6.3e-02 |
ABO ARHGAP15 DKFZp761E198 EFEMP2 MLXIP MPHOSPH9 NDUFAF1 NEK6 PACSIN1 RFTN2 RIN3 RP11-373D23.3 SNX32 SULT1A2 SUOX TRAF3 TRAFD1 WBP1L ZBTB38 ZBTB7B |
Pulse rate, automated reading |
1.20 |
9 |
3 |
6.7 |
0.34 |
3.8e-01 |
ABO CALCRL PACSIN1 SIK2 SUGT1L1 SUOX TOM1L2 ZBTB38 ZKSCAN5 |
Alcohol intake frequency. |
1.42 |
5 |
1 |
2.2 |
-0.70 |
1.9e-01 |
NAGLU NFKB1 STAT6 SULT1A2 SUOX |
Comparative height size at age 10 |
1.35 |
13 |
9 |
20.0 |
-0.16 |
6.0e-01 |
EIF1AD IQGAP1 IRF1 MPHOSPH9 PACSIN1 SUGT1L1 SULT1A2 TMEM170A TRAFD1 WBP1L ZBTB38 ZBTB7B ZNF774 |
Suffer from 'nerves' |
0.92 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
RERE |
Overall health rating |
1.02 |
3 |
1 |
2.2 |
0.00 |
1.0e+00 |
RFTN2 TOM1L2 ZNF652 |
Supplements: Vitamin C |
1.01 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
ORMDL3 |
Knee pain experienced in last month |
1.36 |
2 |
0 |
0.0 |
0.00 |
1.0e+00 |
DEXI RP11-396B14.2 |
Hypertension (Self-reported) |
1.95 |
17 |
6 |
13.3 |
-0.05 |
8.6e-01 |
ABO ADAM1A CHP CLCN6 CLIC4 FES LOC729082 NDUFAF1 PCNXL3 POLI RERE RTF1 SGSM2 SIK2 SUOX TRAFD1 ZNF652 |
Illnesses of father: Heart disease |
1.65 |
2 |
1 |
2.2 |
0.00 |
1.0e+00 |
ABO FES |
Forced expiratory volume in 1-second (FEV1), predicted |
1.25 |
4 |
2 |
4.4 |
0.52 |
4.8e-01 |
MGAT5 PACSIN1 WBP1L ZBTB38 |
Whole body fat-free mass |
1.79 |
22 |
15 |
33.3 |
-0.40 |
6.2e-02 |
ARHGAP15 DKFZp761E198 EFEMP2 IRF1 MLXIP MPHOSPH9 NDUFAF1 PACSIN1 PEMT RFTN2 RIN3 RP11-373D23.3 SNX32 SPPL3 STAT6 SULT1A2 SUOX TRAF3 TRAFD1 WBP1L ZBTB38 ZBTB7B |
Leg fat-free mass (right) |
1.71 |
22 |
10 |
22.2 |
-0.43 |
4.4e-02 |
ARHGAP15 DKFZp761E198 EFEMP2 IRF1 JAZF1 MLXIP MPHOSPH9 MSTO2P PACSIN1 PEMT RFTN2 RIN3 RP11-373D23.3 SGSM2 SNX32 SPPL3 SULT1A2 SUOX TRAF3 TRAFD1 ZBTB38 ZBTB7B |
Arm fat percentage (left) |
1.35 |
14 |
9 |
20.0 |
-0.29 |
3.2e-01 |
ABO ARHGAP15 CHP LOC115110 MLXIP NAGLU NUSAP1 OIP5 PACSIN1 RERE SGSM2 SULT1A2 TRAF3 ZNHIT3 |
Mood swings |
0.95 |
2 |
1 |
2.2 |
0.00 |
1.0e+00 |
CD40 TEF |
Loneliness, isolation |
0.85 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
RERE |
Ever had bowel cancer screening |
1.27 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
SIK2 |
Diabetes diagnosed by doctor |
1.24 |
2 |
0 |
0.0 |
0.00 |
1.0e+00 |
JAZF1 NAGLU |
Qualifications: nursing, teaching |
0.96 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
MPHOSPH9 |
Mouth/teeth dental problems: Mouth ulcers |
1.91 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
NFKB1 |
Medication for cholesterol |
1.12 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
TRAFD1 |
Asthma (self-reported) |
13.98 |
63 |
47 |
104.4 |
0.91 |
3.0e-36 |
AHI1 BACH2 CAMK4 CASC3 CD247 DEXI EFEMP2 ERBB2 FAM114A1 GLDC GPR182 GSDMA IL18RAP IL1R1 IL1RL1 IL7R IRF1 JAZF1 JMJD5 KIAA1109 KIAA1432 KIF3A LINGO4 LRRC32 MED24 NAGLU NDFIP1 NDUFAF1 NEK6 NRROS ORMDL3 POLI PPOX PRKCQ RANBP6 RERE RIN3 RP11-396B14.2 RP11-876N24.4 RP11-876N24.5 RTF1 S100A11 SCML4 SIK2 SLC25A46 SLC9A2 SMAD3 SMARCE1 SMCP SPATA5 SPPL3 STAT6 STMN3 SUOX TEF TLR1 TLR10 TMEM232 TNFSF4 TSLP UBAC2 WDR36 ZNF652 |
Medication: Aspirin |
1.29 |
2 |
0 |
0.0 |
0.00 |
1.0e+00 |
FES SIK2 |
Illnesses of father: None of the above (group 1) |
1.49 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
FES |
Forced expiratory volume in 1-second (FEV1), predicted percentage |
1.45 |
3 |
1 |
2.2 |
-0.65 |
3.5e-01 |
ERBB2 ORMDL3 TMEM170A |
Whole body water mass |
1.78 |
22 |
14 |
31.1 |
-0.41 |
6.0e-02 |
ARHGAP15 DKFZp761E198 EFEMP2 IRF1 MLXIP MPHOSPH9 NDUFAF1 PACSIN1 PEMT RFTN2 RIN3 RP11-373D23.3 SNX32 SPPL3 STAT6 SULT1A2 SUOX TRAF3 TRAFD1 WBP1L ZBTB38 ZBTB7B |
Leg predicted mass (right) |
1.71 |
23 |
10 |
22.2 |
-0.45 |
3.0e-02 |
ARHGAP15 DKFZp761E198 EFEMP2 IRF1 JAZF1 MLXIP MPHOSPH9 MSTO2P NAGLU PACSIN1 PEMT RFTN2 RIN3 RP11-373D23.3 SGSM2 SNX32 SPPL3 SULT1A2 SUOX TRAF3 TRAFD1 ZBTB38 ZBTB7B |
Arm fat mass (left) |
1.45 |
16 |
11 |
24.4 |
-0.63 |
9.6e-03 |
ARHGAP15 EFEMP2 FOXO1 LOC115110 MLXIP NAGLU PACSIN1 RERE SGSM2 SNX32 SULT1A2 SUOX TRAF3 ZBTB38 ZBTB7B ZNHIT3 |
Number of self-reported non-cancer illnesses |
2.98 |
10 |
2 |
4.4 |
0.82 |
2.2e-03 |
CLCN6 IL1RL1 LINGO4 LRRC32 ORMDL3 RGS14 RP11-396B14.2 STMN3 TRAFD1 ZNF652 |
Miserableness |
1.03 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
ORMDL3 |
Medication: Blood pressure |
1.65 |
5 |
2 |
4.4 |
-0.47 |
4.2e-01 |
CHP CLCN6 FES SIK2 TRAFD1 |
High cholesterol (Self-reported) |
1.12 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
ABO |
Medication: Bendroflumethiazide |
1.23 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
FES |
Medication: Paracetamol |
1.08 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
STAT6 |
Medication: Lisinopril |
1.03 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
MLXIP |
Medication: Atorvastatin |
1.34 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
ABO |
Illnesses of father: High blood pressure |
1.35 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
FES |
Alcohol drinker status: Never |
1.48 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
SLC9A2 |
Ever smoked |
1.20 |
2 |
0 |
0.0 |
0.00 |
1.0e+00 |
PSMG1 WBP1L |
Basal metabolic rate |
1.75 |
21 |
14 |
31.1 |
-0.40 |
6.9e-02 |
ARHGAP15 DKFZp761E198 EFEMP2 FOXO1 IRF1 MLXIP MPHOSPH9 PACSIN1 RFTN2 RIN3 RP11-373D23.3 SNX32 SPPL3 SULT1A2 SUOX TRAF3 TRAFD1 WBP1L ZBTB38 ZBTB7B ZNHIT3 |
Leg fat percentage (left) |
1.35 |
12 |
8 |
17.8 |
0.27 |
3.9e-01 |
MLXIP MPHOSPH9 NUSAP1 OIP5 PACSIN1 RERE SMARCE1 SNX32 STMN3 SULT1A2 TRAF3 ZNHIT3 |
Arm fat-free mass (left) |
1.82 |
20 |
15 |
33.3 |
-0.41 |
7.3e-02 |
ABO ARHGAP15 DKFZp761E198 EFEMP2 MLXIP MPHOSPH9 NEK6 PACSIN1 RFTN2 RIN3 RP11-373D23.3 SNX32 SULT1A2 SUOX TRAF3 TRAFD1 WBP1L ZBTB38 ZBTB7B ZNHIT3 |
Number of operations (self-reported) |
1.54 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
DEXI |
Irritability |
0.96 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
TEF |
Ever had prostate specific antigen (PSA) test |
1.45 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
ZBTB38 |
Diastolic blood pressure, automated reading |
1.97 |
20 |
12 |
26.7 |
0.15 |
5.3e-01 |
ABO ADAM1A CHP CLCN6 CLIC4 FES LOC729082 MPHOSPH9 NDUFAF1 NUSAP1 OIP5 RERE RTF1 SCAMP2 SGSM2 SLC15A2 STMN3 SUOX TRAFD1 ZNF652 |
Unable to work because of sickness or disability |
0.85 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
RFTN2 |
Myopia |
1.16 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
STAT6 |
Vascular/heart problems diagnosed by doctor |
1.98 |
15 |
6 |
13.3 |
-0.03 |
9.0e-01 |
ABO ADAM1A CHP CLCN6 FES LOC729082 NDUFAF1 OIP5 RERE RTF1 SGSM2 SIK2 SUOX TRAFD1 ZNF652 |
Cholesterol lowering medication |
1.17 |
2 |
1 |
2.2 |
0.00 |
1.0e+00 |
ABO CALCRL |
Pain experienced in last month |
1.23 |
2 |
1 |
2.2 |
0.00 |
1.0e+00 |
STAT6 SUOX |
Heart attack/myocardial infarction (self-reported) |
1.17 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
ZNF652 |
Deep venous thrombosis (DVT) (self-reported) |
2.13 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
ABO |
Impedance of whole body |
1.80 |
21 |
14 |
31.1 |
0.60 |
4.3e-03 |
ABO C11orf68 CFL1 DKFZp761E198 EFEMP2 FCHSD1 JAZF1 MED24 NEK6 PACSIN1 RFTN2 RIN3 RP11-876N24.4 SGSM2 SNX32 SUOX TEF TMEM170A ZBTB7B ZNF652 ZNHIT3 |
Leg fat mass (left) |
1.49 |
15 |
9 |
20.0 |
-0.41 |
1.3e-01 |
ARHGAP15 EFEMP2 MLXIP NAGLU PACSIN1 RERE RP11-373D23.3 SNX32 STMN3 SULT1A2 SUOX TRAF3 ZBTB38 ZBTB7B ZNHIT3 |
Arm predicted mass (left) |
1.84 |
21 |
15 |
33.3 |
-0.44 |
4.3e-02 |
ABO ARHGAP15 DKFZp761E198 EFEMP2 FOXO1 MLXIP MPHOSPH9 NEK6 PACSIN1 RFTN2 RIN3 RP11-373D23.3 SNX32 SULT1A2 SUOX TRAF3 TRAFD1 WBP1L ZBTB38 ZBTB7B ZNHIT3 |